Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2900) 2900
Publication (208) 208
Book Review (24) 24
Book Chapter (10) 10
Magazine Article (10) 10
Newsletter (6) 6
Conference Proceeding (2) 2
Dissertation (1) 1
Newspaper Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2282) 2282
acetazolamide - therapeutic use (1911) 1911
male (1236) 1236
female (1141) 1141
acetazolamide (1045) 1045
adult (777) 777
middle aged (696) 696
index medicus (659) 659
aged (466) 466
carbonic anhydrase inhibitors - therapeutic use (435) 435
ophthalmology (380) 380
animals (377) 377
clinical neurology (326) 326
diuretics - therapeutic use (296) 296
adolescent (279) 279
acetazolamide - pharmacology (271) 271
glaucoma - drug therapy (255) 255
intraocular pressure - drug effects (239) 239
child (221) 221
treatment outcome (221) 221
acetazolamide - administration & dosage (213) 213
pharmacology & pharmacy (211) 211
drug therapy, combination (185) 185
acetazolamide - adverse effects (175) 175
anticonvulsants - therapeutic use (160) 160
acute disease (149) 149
time factors (137) 137
altitude sickness - prevention & control (135) 135
rats (134) 134
neurosciences (131) 131
pseudotumor cerebri - drug therapy (127) 127
follow-up studies (125) 125
intraocular pressure (125) 125
carbonic anhydrase inhibitors - pharmacology (123) 123
surgery (121) 121
double-blind method (120) 120
visual acuity (120) 120
pediatrics (116) 116
aged, 80 and over (115) 115
medicine, general & internal (115) 115
retrospective studies (114) 114
prospective studies (112) 112
child, preschool (111) 111
altitude (109) 109
glaucoma (108) 108
magnetic resonance imaging (107) 107
administration, oral (105) 105
pilocarpine - therapeutic use (101) 101
carbonic anhydrase (99) 99
dexamethasone - therapeutic use (99) 99
hydrogen-ion concentration (99) 99
pseudotumor cerebri (99) 99
drug therapy (96) 96
infant (95) 95
risk factors (94) 94
care and treatment (93) 93
carbonic anhydrase inhibitors (91) 91
carbonic anhydrase inhibitors - administration & dosage (91) 91
idiopathic intracranial hypertension (91) 91
hypertension (89) 89
pseudotumor cerebri - diagnosis (88) 88
macular edema - drug therapy (86) 86
neurology (86) 86
timolol - therapeutic use (86) 86
medicine & public health (85) 85
intracranial hypertension (84) 84
hypoxia (83) 83
glaucoma - therapy (82) 82
diagnosis, differential (81) 81
dose-response relationship, drug (78) 78
mice (78) 78
research (78) 78
chronic disease (77) 77
sulfonamides - therapeutic use (77) 77
furosemide - therapeutic use (74) 74
diagnosis (73) 73
fluorescein angiography (72) 72
young adult (72) 72
administration, topical (70) 70
altitude sickness - drug therapy (69) 69
papilledema (68) 68
rabbits (68) 68
management (67) 67
pregnancy (66) 66
research article (66) 66
diuretics (65) 65
papilledema - etiology (65) 65
analysis (64) 64
antihypertensive agents - therapeutic use (64) 64
clinical trials as topic (64) 64
pseudotumor cerebri - complications (64) 64
pressure (63) 63
carbonic anhydrase inhibitors - adverse effects (62) 62
headache - etiology (62) 62
prevention (62) 62
chemistry, medicinal (61) 61
drugs (61) 61
cerebrovascular circulation - drug effects (60) 60
headache (60) 60
prognosis (60) 60
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2418) 2418
German (141) 141
French (91) 91
Spanish (54) 54
Japanese (48) 48
Italian (47) 47
Russian (41) 41
Romanian (19) 19
Czech (13) 13
Dutch (10) 10
Danish (9) 9
Polish (6) 6
Portuguese (6) 6
Hebrew (5) 5
Norwegian (4) 4
Hungarian (3) 3
Finnish (2) 2
Serbian (2) 2
Swedish (2) 2
Chinese (1) 1
Croatian (1) 1
Korean (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors
by Supuran, Claudiu T
Expert Opinion on Drug Metabolism & Toxicology, ISSN 1742-5255, 04/2016, Volume 12, Issue 4, pp. 423 - 431
Introduction: Carbonic anhydrase inhibitors (CAIs) of the sulfonamide and sulfamate type are clinically used drugs as diuretics, antiglaucoma, antiepileptic,... 
dorzolamide | methazolamide | brinzolamide | inhibitor | celecoxib | sultiame | acetazolamide | carbonic anhydrase | zonisamide | topiramate | IN-VITRO INHIBITION | BIOCHEMISTRY & MOLECULAR BIOLOGY | TARGETING TUMOR HYPOXIA | ANTICONVULSANT | TOXICITY | RENAL-CELL CARCINOMA | SALICYLIC-ACID | PATENT | PHARMACOLOGY & PHARMACY | ISOZYME-II | TOXICOLOGY | Thiophenes - therapeutic use | Drug-Related Side Effects and Adverse Reactions - prevention & control | Thiazines - therapeutic use | Humans | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Anti-Obesity Agents - therapeutic use | Contraindications | Drug Interactions | Carbonic Anhydrase Inhibitors - therapeutic use | Anticonvulsants - therapeutic use | Clinical Trials as Topic | Celecoxib - therapeutic use | Fructose - therapeutic use | Fructose - analogs & derivatives | Phenobarbital - therapeutic use | Sulfanilamides - therapeutic use | Methazolamide - therapeutic use | Sulfonamides - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Sulfonic Acids - therapeutic use | Phenobarbital - analogs & derivatives | Isoxazoles - therapeutic use | Acetazolamide - therapeutic use | Benzodiazepines - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Interventions for treating acute high altitude illness
by Simancas-Racines, Daniel and Arevalo-Rodriguez, Ingrid and Osorio, Dimelza and Franco, Juan V.A and Xu, Yihan and Hidalgo, Ricardo
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 06/2018, Volume 2018, Issue 6, p. CD009567
Background Acute high altitude illness is defined as a group of cerebral and pulmonary syndromes that can occur during travel to high altitudes. It is more... 
OXYGEN | MEDICINE, GENERAL & INTERNAL | DEXAMETHASONE | HEADACHE | CLINICAL-EFFICACY | PREVENTION | ACETAZOLAMIDE | GAMOW BAG | ACUTE MOUNTAIN-SICKNESS | INHALED NITRIC-OXIDE | PULMONARY-EDEMA | Acute Disease | Cyclohexanecarboxylic Acids - therapeutic use | Glucocorticoids - therapeutic use | Gabapentin | Humans | Anticonvulsants - therapeutic use | Atmospheric Pressure | Hypertension, Pulmonary - therapy | Magnesium - therapeutic use | Randomized Controlled Trials as Topic | Dexamethasone - therapeutic use | Adolescent | Amines - therapeutic use | Altitude Sickness - therapy | Adult | gamma-Aminobutyric Acid - therapeutic use | Acetazolamide - therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Review of the Diagnosis and Treatment of Periodic Paralysis
by Statland, Jeffrey M and Fontaine, Bertrand and Hanna, Michael G and Johnson, Nicholas E and Kissel, John T and Sansone, Valeria A and Shieh, Perry B and Tawil, Rabi N and Trivedi, Jaya and Cannon, Stephen C and Griggs, Robert C
Muscle & Nerve, ISSN 0148-639X, 04/2018, Volume 57, Issue 4, pp. 522 - 530
ABSTRACT Periodic paralyses (PPs) are rare neuromuscular disorders caused by mutations in skeletal muscle sodium, calcium, and potassium channel genes. PPs... 
treatment | periodic paralyses | review | acetazolamide | Andersen‐Tawil syndrome | channelopathies | dichlorphenamide | Andersen-Tawil syndrome | ACETAZOLAMIDE TREATMENT | EXERCISE TEST | FLECAINIDE | ANDERSEN-TAWIL-SYNDROME | SKELETAL-MUSCLE CHANNELOPATHIES | CHANNEL GENE SCN4A | WEAKNESS | KCNJ2 MUTATIONS | NEUROSCIENCES | CLINICAL NEUROLOGY | VENTRICULAR-ARRHYTHMIAS | CARBONIC-ANHYDRASE INHIBITORS | Behavior Therapy | Humans | Andersen Syndrome - diagnosis | Paralysis, Hyperkalemic Periodic - therapy | Hypokalemic Periodic Paralysis - diagnosis | Anti-Arrhythmia Agents - therapeutic use | Paralyses, Familial Periodic - therapy | Andersen Syndrome - therapy | Paralyses, Familial Periodic - diagnosis | Paralysis, Hyperkalemic Periodic - diagnosis | Potassium - therapeutic use | Diuretics - therapeutic use | Hypokalemic Periodic Paralysis - therapy | Acetazolamide - therapeutic use | Hydrochlorothiazide - therapeutic use | Carbonic Anhydrase Inhibitors - therapeutic use | Diuretics, Potassium Sparing - therapeutic use | Care and treatment | Gene mutations | Therapeutics | Muscles | Diuretics | Paralysis | Diagnosis | Genetic screening | Homeopathy | Materia medica and therapeutics | Calcium | Heredity | Skeletal muscle | Sodium | Carbonic anhydrase | Mutation | Potassium | Neuromuscular system | Invited Reviews | Invited Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Wilderness Medical Society Consensus Guidelines for the Prevention and Treatment of Acute Altitude Illness
by Luks, Andrew M., MD and McIntosh, Scott E., MD, MPH and Grissom, Colin K., MD and Auerbach, Paul S., MD, MS and Rodway, George W., PhD, APRN and Schoene, Robert B., MD and Zafren, Ken, MD and Hackett, Peter H., MD and Wilderness Medical Society
Wilderness & Environmental Medicine, ISSN 1080-6032, 2010, Volume 21, Issue 2, pp. 146 - 155
To provide guidance to clinicians about best practices, the Wilderness Medical Society (WMS) convened an expert panel to develop evidence-based guidelines for... 
Emergency | dexamethasone | nifedipine | high altitude | tadalafil | high altitude pulmonary edema | salmeterol | acetazolamide | acute mountain sickness | high altitude cerebral edema | sildenafil | Acute mountain sickness | High altitude | High altitude pulmonary edema | Tadalafil | Dexamethasone | Salmeterol | Acetazolamide | Sildenafil | High altitude cerebral edema | Nifedipine | SPORT SCIENCES | CEREBRAL EDEMA | GINKGO-BILOBA | RANDOMIZED-TRIAL | PULMONARY-EDEMA | PROPHYLAXIS | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | SIMULATED DESCENT | ACUTE MOUNTAIN-SICKNESS | Sulfones - therapeutic use | Acute Disease | Salmeterol Xinafoate | Humans | Albuterol - analogs & derivatives | Brain Edema - therapy | Mountaineering | Piperazines - therapeutic use | Societies | Altitude Sickness - prevention & control | Brain Edema - prevention & control | Sildenafil Citrate | Dexamethasone - therapeutic use | Pulmonary Edema - therapy | Nifedipine - therapeutic use | Altitude Sickness - therapy | Pulmonary Edema - prevention & control | Albuterol - therapeutic use | Purines - therapeutic use | Wilderness Medicine - standards | Acetazolamide - therapeutic use | Carbolines - therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Treatment for HIV-associated cryptococcal meningitis
by Tenforde, Mark W and Shapiro, Adrienne E and Rouse, Benjamin and Jarvis, Joseph N and Li, Tianjing and Eshun-Wilson, Ingrid and Ford, Nathan
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 07/2018, Volume 2018, Issue 7, pp. CD005647 - CD005647
Background Cryptococcal meningitis is a severe fungal infection that occurs primarily in the setting of advanced immunodeficiency and remains a major cause of... 
HIV Infections [complications] | Health Resources [supply & distribution] | Flucytosine [supply & distribution; therapeutic use] | Humans | ANTIRETROVIRAL THERAPY | Fluconazole [supply & distribution; therapeutic use] | MAINTENANCE THERAPY | MEDICINE, GENERAL & INTERNAL | Adult | Intracranial Hypertension [drug therapy] | Antifungal Agents [supply & distribution; therapeutic use] | Antihypertensive Agents [adverse effects] | Acute Disease | RANDOMIZED-TRIAL | FUNGAL BURDEN | PLUS FLUCYTOSINE | Meningitis, Cryptococcal [drug therapy] | Amphotericin B [supply & distribution; therapeutic use] | HIGH-DOSE FLUCONAZOLE | Acetazolamide [adverse effects] | DOUBLE-BLIND | Developing Countries | INFECTED PATIENTS | PLACEBO-CONTROLLED TRIAL | AMPHOTERICIN-B DEOXYCHOLATE | Amphotericin B - supply & distribution | Drug Administration Schedule | Meningitis, Cryptococcal - drug therapy | Fluconazole - supply & distribution | Induction Chemotherapy - methods | Health Resources - supply & distribution | Fluconazole - therapeutic use | Antifungal Agents - supply & distribution | Antifungal Agents - therapeutic use | Meningitis, Cryptococcal - mortality | Intracranial Hypertension - drug therapy | Acetazolamide - adverse effects | Flucytosine - therapeutic use | HIV Infections - complications | Network Meta-Analysis | Amphotericin B - therapeutic use | Drug Therapy, Combination | Flucytosine - supply & distribution | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Interventions for preventing high altitude illness: Part 2. Less commonly-used drugs
by Gonzalez Garay, Alejandro Gabriel G and Molano Franco, Daniel and Nieto Estrada, Víctor H and Martí-Carvajal, Arturo J and Arevalo-Rodriguez, Ingrid
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 03/2018, Volume 2018, Issue 3, p. CD012983
Background High altitude illness (HAI) is a term used to describe a group of mainly cerebral and pulmonary syndromes that can occur during travel to elevations... 
MEDICINE, GENERAL & INTERNAL | SPIRONOLACTONE PROPHYLAXIS | CEREBRAL EDEMA | GINKGO-BILOBA | GUIDELINES | ACETAZOLAMIDE | CROSS-OVER TRIALS | HYPOXIA | TRIAL SEQUENTIAL-ANALYSIS | ACUTE MOUNTAIN-SICKNESS | PULMONARY-EDEMA | Cathartics - adverse effects | Organometallic Compounds - adverse effects | Humans | Sumatriptan - therapeutic use | Citric Acid - therapeutic use | Altitude Sickness - prevention & control | Cathartics - therapeutic use | Citric Acid - adverse effects | Randomized Controlled Trials as Topic | Organometallic Compounds - therapeutic use | Diuretics - therapeutic use | Acetazolamide - therapeutic use | Spironolactone - therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Diagnostic and therapeutic challenges
by Dhrami-Gavazi, Elona and Goldberg, Naomi R and Freund, K. Bailey and Vora, Robin A
Retina, ISSN 0275-004X, 05/2016, Volume 36, Issue 5, pp. 1045 - 1048
Diagnosis, Differential | Glucocorticoids - therapeutic use | Multiple Sclerosis - diagnosis | Administration, Oral | Tomography, Optical Coherence | Humans | Male | Macular Edema - diagnosis | Macular Edema - drug therapy | Adult | Diuretics - therapeutic use | Acetazolamide - therapeutic use | Drug Therapy, Combination | Prednisone - therapeutic use | Fluorescein Angiography | Multiple Sclerosis - drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text High-Altitude Illness
by Hackett, Peter H and Roach, Robert C
The New England Journal of Medicine, ISSN 0028-4793, 07/2001, Volume 345, Issue 2, pp. 107 - 114
The term “high-altitude illness” is used to describe the cerebral and pulmonary syndromes that can develop in unacclimatized persons shortly after ascent to... 
Diagnosis, Differential | Brain Edema - etiology | Oxygen - therapeutic use | Humans | Risk Factors | Calcium Channel Blockers - therapeutic use | Brain Edema - therapy | Pulmonary Edema - etiology | Altitude Sickness - diagnosis | Pulmonary Edema - therapy | Nifedipine - therapeutic use | Pulmonary Edema - diagnosis | Altitude Sickness - complications | Altitude Sickness - physiopathology | Altitude Sickness - therapy | Diuretics - therapeutic use | Acetazolamide - therapeutic use | Mountain sickness | Care and treatment | Health care | Travel | Altitudes | Medical disorders
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 - 2013)
by Carta, Fabrizio and Supuran, Claudiu T
Expert Opinion on Therapeutic Patents, ISSN 1354-3776, 06/2013, Volume 23, Issue 6, pp. 681 - 691
Introduction: The benzothiadiazines and high ceiling diuretics (hydrochlorothiazide, hydroflumethiazide, quinethazone, metolazone, chlorthalidone, indapamide,... 
indapamide | hydroflumethiazide | quinethazone | sulfonamide | carbonic anhydrase inhibitor | furosemide and bumetanide | hydrochlorothiazide | chlorthalidone | metolazone | diuretic | Diuretic | Chlorthalidone | Indapamide | Sulfonamide | Carbonic anhydrase inhibitor | Furosemide and bumetanide | Hydroflumethiazide | Metolazone | Hydrochlorothiazide | Quinethazone | CHEMISTRY, MEDICINAL | MEDICINE, LEGAL | ACETAZOLAMIDE | BLOOD-FLOW | THERAPEUTIC APPLICATIONS | RAY CRYSTAL-STRUCTURES | COLORED MICROSPHERES | PHARMACOLOGY & PHARMACY | ISOZYME-II | ESSENTIAL-HYPERTENSION | WATER-MOLECULES | KIDNEY | Diuretics - pharmacology | Humans | Kidney - enzymology | Carbonic Anhydrase Inhibitors - pharmacology | Sulfonamides - pharmacology | Patents as Topic | Carbonic Anhydrases - metabolism | Animals | Sulfonamides - therapeutic use | Drug Design | Diuretics - therapeutic use | Carbonic Anhydrases - drug effects | Carbonic Anhydrase Inhibitors - therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual Loss: The Idiopathic Intracranial Hypertension Treatment Trial
by Wall, Michael and McDermott, Michael P and Kieburtz, Karl D and Corbett, James J and Feldon, Steven E and Friedman, Deborah I and Katz, David M and Keltner, John L and Schron, Eleanor B and Kupersmith, Mark J and NORDIC Idiopathic Intracranial and NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee
JAMA, ISSN 0098-7484, 04/2014, Volume 311, Issue 16, pp. 1641 - 1651
IMPORTANCE Acetazolamide is commonly used to treat idiopathic intracranial hypertension (IIH), but there is insufficient information to establish an evidence... 
VALIDATION | PRESSURE | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | PSEUDOTUMOR CEREBRI | Pseudotumor Cerebri - drug therapy | Pseudotumor Cerebri - diet therapy | Humans | Male | Treatment Outcome | Combined Modality Therapy | Vision Disorders - drug therapy | Weight Loss | Diet, Sodium-Restricted | Pseudotumor Cerebri - complications | Quality of Life | Adult | Female | Acetazolamide - therapeutic use | Carbonic Anhydrase Inhibitors - therapeutic use | Vision Disorders - etiology | Acetazolamide | Dosage and administration | Research | Drug therapy | Intracranial hypertension | Hypertension | Clinical trials | Inhibitor drugs | Medical treatment | Clinical outcomes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights